Background: SARS-CoV-2 infection has, as of April 2021, affected >133 million people worldwide, causing >2.5 million deaths. Because the large majority of individuals infected with SARS-CoV-2 are asymptomatic, major concerns have been raised about possible long-term consequences of the infection. Methods: Wedeveloped an antigen capture assay to detect SARS-CoV-2 spike protein in urine samples from patients with COVID-19whose diagnosis was confirmed by positive PCR results from nasopharyngeal swabs (NP-PCR+) forSARS-CoV-2. We used a collection of 233 urine samples from 132 participants from Yale New Haven Hospital and the Children's Hospital of Philadelphia that were obtained during the pandemic (106 NP-PCR+ and 26 NP-PCR-), and a collection of 20 urine samples from 20 individuals collected before the pandemic. Results: Our analysis identified 23 out of 91 (25%) NP-PCR+ adult participants with SARS-CoV-2 spike S1 protein in urine (Ur-S+). Interestingly, although all NP-PCR+ children were Ur-S-, one child who was NP-PCR- was found to be positive for spike protein in their urine. Of the 23 adults who were Ur-S+, only one individual showed detectable viral RNA in urine. Our analysis further showed that 24% and 21% of adults who were NP-PCR+ had high levels of albumin and cystatin C, respectively, in their urine. Among individuals with albuminuria (>0.3 mg/mg of creatinine), statistical correlation could be found between albumin and spike protein in urine. Conclusions: Together, our data showed that one of four individuals infected with SARS-CoV-2 develop renal abnormalities, such as albuminuria. Awareness about the long-term effect of these findings is warranted.
Background: SARS-CoV-2 infection has, as of April 2021, affected >133 million people worldwide, causing >2.5 million deaths. Because the large majority of individuals infected with SARS-CoV-2 are asymptomatic, major concerns have been raised about possible long-term consequences of the infection. Methods: Wedeveloped an antigen capture assay to detect SARS-CoV-2 spike protein in urine samples from patients with COVID-19whose diagnosis was confirmed by positive PCR results from nasopharyngeal swabs (NP-PCR+) forSARS-CoV-2. We used a collection of 233 urine samples from 132 participants from Yale New Haven Hospital and the Children's Hospital of Philadelphia that were obtained during the pandemic (106 NP-PCR+ and 26 NP-PCR-), and a collection of 20 urine samples from 20 individuals collected before the pandemic. Results: Our analysis identified 23 out of 91 (25%) NP-PCR+ adult participants with SARS-CoV-2 spike S1 protein in urine (Ur-S+). Interestingly, although all NP-PCR+ children were Ur-S-, one child who was NP-PCR- was found to be positive for spike protein in their urine. Of the 23 adults who were Ur-S+, only one individual showed detectable viral RNA in urine. Our analysis further showed that 24% and 21% of adults who were NP-PCR+ had high levels of albumin and cystatin C, respectively, in their urine. Among individuals with albuminuria (>0.3 mg/mg of creatinine), statistical correlation could be found between albumin and spike protein in urine. Conclusions: Together, our data showed that one of four individuals infected with SARS-CoV-2 develop renal abnormalities, such as albuminuria. Awareness about the long-term effect of these findings is warranted.
Authors: Daniel Batlle; Maria Jose Soler; Matthew A Sparks; Swapnil Hiremath; Andrew M South; Paul A Welling; Sundararaman Swaminathan Journal: J Am Soc Nephrol Date: 2020-05-04 Impact factor: 10.121
Authors: N S Zhong; B J Zheng; Y M Li; Z H Xie; K H Chan; P H Li; S Y Tan; Q Chang; J P Xie; X Q Liu; J Xu; D X Li; K Y Yuen; Y Guan Journal: Lancet Date: 2003-10-25 Impact factor: 79.321
Authors: Anne L Wyllie; John Fournier; Arnau Casanovas-Massana; Melissa Campbell; Maria Tokuyama; Pavithra Vijayakumar; Joshua L Warren; Bertie Geng; M Catherine Muenker; Adam J Moore; Chantal B F Vogels; Mary E Petrone; Isabel M Ott; Peiwen Lu; Arvind Venkataraman; Alice Lu-Culligan; Jonathan Klein; Rebecca Earnest; Michael Simonov; Rupak Datta; Ryan Handoko; Nida Naushad; Lorenzo R Sewanan; Jordan Valdez; Elizabeth B White; Sarah Lapidus; Chaney C Kalinich; Xiaodong Jiang; Daniel J Kim; Eriko Kudo; Melissa Linehan; Tianyang Mao; Miyu Moriyama; Ji E Oh; Annsea Park; Julio Silva; Eric Song; Takehiro Takahashi; Manabu Taura; Orr-El Weizman; Patrick Wong; Yexin Yang; Santos Bermejo; Camila D Odio; Saad B Omer; Charles S Dela Cruz; Shelli Farhadian; Richard A Martinello; Akiko Iwasaki; Nathan D Grubaugh; Albert I Ko Journal: N Engl J Med Date: 2020-08-28 Impact factor: 176.079
Authors: Jordan D Zehr; Sergei L Kosakovsky Pond; Darren P Martin; Kristina Ceres; Gary R Whittaker; Jean K Millet; Laura B Goodman; Michael J Stanhope Journal: Viruses Date: 2022-04-21 Impact factor: 5.818
Authors: Laura E Lamb; Ryan Timar; Melissa Wills; Sorabh Dhar; Steve M Lucas; Dragana Komnenov; Michael B Chancellor; Nivedita Dhar Journal: Int Urol Nephrol Date: 2021-11-17 Impact factor: 2.266
Authors: Stefanos Giannakopoulos; Daniel P Strange; Boonyanudh Jiyarom; Omar Abdelaal; Aaron W Bradshaw; Vivek R Nerurkar; Monika A Ward; Jackson Bakse; Jonathan Yap; Selena Vanapruks; William Boisvert; Michelle D Tallquist; Cecilia Shikuma; Hooman Sadri-Ardekani; Philip Clapp; Sean Murphy; Saguna Verma Journal: bioRxiv Date: 2022-09-22